International Isotopes, Inc.
This article was originally published in The Gray Sheet
Executive SummaryPrivate placement of common stock and warrants to company management, directors, several shareholders and three investment institutions grosses over $10 mil., the firm reports Dec. 15. The Denton, Texas maker of brachytherapy devices plans to use the proceeds to complete installation and testing of equipment including a 70MeV LINAC and 42 MeV Cyclotron, continue expansion of finished radiopharmaceutical and radiochemistry capabilities, and produce radioisotopes, radiochemicals and brachytherapy devices
You may also be interested in...
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.